AR047922A1 - Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos - Google Patents

Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos

Info

Publication number
AR047922A1
AR047922A1 ARP050100812A ARP050100812A AR047922A1 AR 047922 A1 AR047922 A1 AR 047922A1 AR P050100812 A ARP050100812 A AR P050100812A AR P050100812 A ARP050100812 A AR P050100812A AR 047922 A1 AR047922 A1 AR 047922A1
Authority
AR
Argentina
Prior art keywords
obtaining
pentafluorsulfanilo
pharmaceutical agents
new derivatives
compounds
Prior art date
Application number
ARP050100812A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR047922A1 publication Critical patent/AR047922A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Son objetos de la presente los compuestos de la formula (1), sus sales farmacéuticamente aceptables, formas enantioméricas, diastereoisomeros y racematos, la obtencion de los compuestos recién mencionados, los medicamentos que los contienen y su fabricacion, así como el uso de los compuestos recién mencionados para el control o prevencion de enfermedades, tales como el cáncer.
ARP050100812A 2004-03-05 2005-03-03 Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos AR047922A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04005275 2004-03-05

Publications (1)

Publication Number Publication Date
AR047922A1 true AR047922A1 (es) 2006-03-01

Family

ID=34895965

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100812A AR047922A1 (es) 2004-03-05 2005-03-03 Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos

Country Status (12)

Country Link
US (1) US7235574B2 (es)
EP (1) EP1725549A1 (es)
JP (1) JP2007526275A (es)
KR (1) KR20060124746A (es)
CN (1) CN1930153A (es)
AR (1) AR047922A1 (es)
AU (1) AU2005229352A1 (es)
BR (1) BRPI0508485A (es)
CA (1) CA2557402A1 (es)
RU (1) RU2006135084A (es)
TW (1) TW200531688A (es)
WO (1) WO2005095388A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7317124B2 (en) * 2003-11-13 2008-01-08 Sanofi-Aventis Deutschland Gmbh Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates
TW200533657A (en) 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
TW200612914A (en) * 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200533346A (en) * 2004-03-18 2005-10-16 Hoffmann La Roche Novel ether derivatives, their manufacture and use as pharmaceutical agents
AR050652A1 (es) * 2004-09-24 2006-11-08 Hoffmann La Roche Derivados de oxazol, preparacion y uso como inhibidores de la tirosina quinasa
WO2008101212A2 (en) * 2007-02-16 2008-08-21 State University Of New York At Albany Pentafluorosulfanyl containing amino acids
JP5418226B2 (ja) * 2007-08-28 2014-02-19 宇部興産株式会社 ペンタフルオロスルファニルベンゼン化合物の製造方法、及び新規なペンタフルオロスルファニルベンゼン化合物
PT2240487E (pt) * 2008-02-05 2012-03-08 Sanofi Sa Triazolopiridazinas como inibidores do par1, sua preparação e utilização como produtos farmacêuticos
DK2242740T3 (da) * 2008-02-05 2013-03-25 Sanofi Sa SF5-derivater som par1-inhibitorer, deres fremstilling og anvendelse som lægemidler
EP2240486B1 (de) * 2008-02-05 2015-09-09 Sanofi Triazoliumsalze als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
EP2661434A4 (en) 2011-01-06 2014-07-09 Beta Pharma Canada Inc NEW URGES FOR THE TREATMENT AND PREVENTION OF CANCER
WO2012111839A1 (en) 2011-02-15 2012-08-23 Ube Industries, Ltd. Industrial methods for producing arylsulfur pentafluorides
US9682931B2 (en) * 2013-11-01 2017-06-20 Ube Industries, Ltd. Aryloyl(oxy or amino)pentafluorosulfanylbenzene compound, pharmaceutically acceptable salt thereof, and prodrugs thereof
CN112920133B (zh) * 2021-01-29 2022-09-16 中国医科大学 (e)-4-甲基-2-(4-(三氟甲基)苯乙烯基)噁唑类化合物及其制备方法与用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2260999C (en) 1996-07-19 2006-07-11 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use in tyrosine kinase inhibition
PE20011178A1 (es) 2000-04-07 2001-11-19 Takeda Chemical Industries Ltd Compuestos heterociclicos y su produccion
US6984653B2 (en) 2001-10-05 2006-01-10 Takeda Pharmaceutical Company Limited Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
JP2003277379A (ja) * 2002-01-17 2003-10-02 Takeda Chem Ind Ltd 含窒素複素環化合物、その製造法および用途
JP2004059452A (ja) * 2002-07-25 2004-02-26 Asahi Glass Co Ltd ペンタフルオロサルファー置換ベンズイミダゾール化合物およびその製造方法
US7596415B2 (en) * 2002-12-06 2009-09-29 Medtronic, Inc. Medical devices incorporating carbon nanotube material and methods of fabricating same
US7259262B2 (en) * 2003-10-24 2007-08-21 Hoffmann-La Roche Inc. Arylazole derivatives, their manufacture and use as pharmaceutical agents
TW200612914A (en) * 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
US7288557B2 (en) * 2004-09-21 2007-10-30 Hoffmann-La Roche Inc. Triazole derivatives
AR050652A1 (es) * 2004-09-24 2006-11-08 Hoffmann La Roche Derivados de oxazol, preparacion y uso como inhibidores de la tirosina quinasa
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives

Also Published As

Publication number Publication date
TW200531688A (en) 2005-10-01
US20050197370A1 (en) 2005-09-08
AU2005229352A1 (en) 2005-10-13
RU2006135084A (ru) 2008-04-10
EP1725549A1 (en) 2006-11-29
CA2557402A1 (en) 2005-10-13
CN1930153A (zh) 2007-03-14
US7235574B2 (en) 2007-06-26
JP2007526275A (ja) 2007-09-13
WO2005095388A1 (en) 2005-10-13
KR20060124746A (ko) 2006-12-05
BRPI0508485A (pt) 2007-07-31

Similar Documents

Publication Publication Date Title
AR047922A1 (es) Nuevos derivados de pentafluorsulfanilo, su obtencion y su utilizacion como agentes farmaceuticos
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY29437A1 (es) Nuevos antagonistas de cgrp
PA8680701A1 (es) Derivados de oxindol
UY30314A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
ECSP088296A (es) Compuestos terapéuticos
CL2004000732A1 (es) Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer.
UY28691A1 (es) Derivados de difenilazetidona
UY28990A1 (es) Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso.
UY28859A1 (es) Antagonistas de cgrp seleccionados, procedimiento para su preparación así como su uso como medicamento
AR038047A1 (es) Agentes terapeuticos
ECSP109934A (es) Compuesto - 946
PA8621901A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
ECSP055535A (es) Derivados de 1-heterociclialquil-3-sulfonilazaindol o azaindol como ligandos de 5-hidroxitriptamina-6
ECSP10010178A (es) Derivados bis-(sulfonilamino) en terapia 066
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
PA8675701A1 (es) Nuevos derivados del fluoreno, composiciones que los contienen y su utilización
UY30460A1 (es) Compuestos terapéuticos
UY29420A1 (es) Derivados de 2-piridona,composiciones que los contienen, procesos de preparación y aplicación
UY28369A1 (es) Agentes terapéuticos
DE602006020295D1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
ECSP045156A (es) Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6
CL2021002480A1 (es) Agonistas compuestos macrocíclicos como de sting

Legal Events

Date Code Title Description
FB Suspension of granting procedure